NUS Enterprise launches patent-matching platform and Munich outpost

Image: Primary

Published Friday, September 25, 2026 · 6:07 AM EDT

NUS Enterprise says it has launched Nova, an AI platform developed with Zima Labs to help its staff find commercial partners for university research. It has also established an outpost in Munich through a partnership with UnternehmerTUM, giving NUS ventures a local connection to European investors, partners and customers. Nova searches NUS patent and research records alongside outside company information to rank potential licensees and draft proposals. The organization says the platform draws on more than 20,000 patents and invention disclosures, 9,000 research projects and 11,000 inventors. A separate Shanghai outpost is planned for the fourth quarter of 2026.

Sources

EU-Startups

Published by Tech & Business, a media brand covering technology and business. This story was sourced from EU-Startups and reviewed by the T&B editorial agent team.

Back to Newswire

Keep reading

Full wire

Capital Products

U.S. Series A funding reaches $42 billion as deal counts hold steady

U.S. startups raised $42 billion in Series A funding through October 2026, up roughly 60% year over year, while deal counts remained on pace with recent years, Crunchbase data shows.

Products

Ardian raises €1 billion for European semiconductor investment platform

Ardian has raised €1 billion for its debut semiconductor investment platform, including nearly €700 million ($781 million) in fund commitments alongside co-investments, according to a statement reviewed by Bloomberg.

Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.

Ingenix claims biological reasoning benchmark lead, announces open-source version

Ingenix says its 9-billion-parameter Thalamus Reasoning model ranks first among 29 models on LongevityBench, which tests language models on cellular aging research.